Pevonedistat, a NEDD8‐activating enzyme inhibitor, induces apoptosis and augments efficacy of chemotherapy and small molecule inhibitors in pre‐clinical models of diffuse large B‐cell lymphoma

We studied the biological activity of pevonedistat, a first‐in‐class NEDD8‐activating enzyme (NAE) inhibitor, in combination with various cytotoxic chemotherapy agents and small molecule inhibitors in lymphoma preclinical models. Pevonedistat induced cell death in activated B‐cell (ABC) diffuse larg...

Descripción completa

Detalles Bibliográficos
Autores principales: Torka, Pallawi, Mavis, Cory, Kothari, Shalin, Belliotti, Sarah, Gu, Juan, Sundaram, Suchitra, Barth, Matthew, Hernandez‐Ilizaliturri, Francisco J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Haematologic Malignancy ‐ Lymphoid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566777/
https://www.ncbi.nlm.nih.gov/pubmed/33073261
http://dx.doi.org/10.1002/jha2.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566777/
https://www.ncbi.nlm.nih.gov/pubmed/33073261
http://dx.doi.org/10.1002/jha2.2

Ejemplares similares